Form 8-K - Current report:
SEC Accession No. 0001193125-16-783506
Filing Date
2016-12-02
Accepted
2016-12-02 11:53:02
Documents
2
Period of Report
2016-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d308192d8k.htm 8-K 26207
2 EX-10.1 d308192dex101.htm EX-10.1 102028
  Complete submission text file 0001193125-16-783506.txt   129506
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 162030297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances